{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:32:49Z","timestamp":1761197569874,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T00:00:00Z","timestamp":1528156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10286-018-0534-y","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T07:30:31Z","timestamp":1528183831000},"page":"567-574","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson\u2019s disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Sebastian J.","family":"Brandl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-8938","authenticated-orcid":false,"given":"Stefan","family":"Braune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,5]]},"reference":[{"issue":"1","key":"534_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"Douglas J. Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56(1):33\u201339","journal-title":"Archives of Neurology"},{"issue":"12","key":"534_CR2","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"3","key":"534_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"534_CR4","first-page":"202","volume":"55","author":"A Satoh","year":"1997","unstructured":"Satoh A, Serita T, Tsujihata M (1997) Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson\u2019s disease: assessment of cardiac sympathetic denervation. Nihon Rinsho 55(1):202\u2013206","journal-title":"Nihon Rinsho"},{"key":"534_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-0404.1998.tb05958.x","volume":"97","author":"S Braune","year":"1998","unstructured":"Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, L\u00fccking CH (1998) Impaired cardiac uptake of meta [123I] iodobenzylguanidine in Parkinson\u2019s disease and autonomic failure. Acta Neurol Scand 97:307\u2013314","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"534_CR6","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","volume":"18","author":"S Orimo","year":"2012","unstructured":"Orimo S, Suzuki M, Inaba A, Mizusawa H (2012) 123I-MIBG myocardial scintigraphy for differentiating Parkinson\u2019s disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 18(5):494\u2013500","journal-title":"Parkinsonism Relat Disord"},{"key":"534_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"M Yoshita","year":"1998","unstructured":"Yoshita M (1998) Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine 123 metaiodobenzyl-guanidine myocardial scintigraphy. J Neurol Sci 155:60\u201367","journal-title":"J Neurol Sci"},{"issue":"6","key":"534_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF02292766","volume":"11","author":"S Braune","year":"2001","unstructured":"Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11(6):351\u2013355","journal-title":"Clin Auton Res"},{"issue":"1","key":"534_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jama.284.1.39","volume":"284","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nagashima K, Murase M, Fujiwara H, Nishida H, Matsuo H, Watanabe S, Satomi K (2000) Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation. JAMA 284(1):44\u201345","journal-title":"JAMA"},{"key":"534_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10286-011-0135-5","volume":"22","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cason E, Stefanelli A, Cocciolillo F, Di Giuda D, Fagioli G, Giordano A (2012) MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis. Clin Auton Res 22:43\u201355","journal-title":"Clin Auton Res"},{"issue":"9","key":"534_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, D\u00fcrr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670\u2013676","journal-title":"Neurology"},{"issue":"15","key":"534_CR12","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1002\/mds.22826","volume":"24","author":"YL Osaki","year":"2009","unstructured":"Osaki YL, Ben-Shlomo Y, Lees AJ, Wenning GK, Quinn NP (2009) A validation exercise on the new consensus criteria for multiple system atrophy. Mov Disord 24(15):2272\u20132276","journal-title":"Mov Disord"},{"key":"534_CR13","first-page":"1620","volume":"28","author":"JC Sisson","year":"1987","unstructured":"Sisson JC, Wieland DM, Sherman P, Mangner TJ, Tobes MC, Jacques S Jr (1987) Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 28:1620\u20131624","journal-title":"J Nucl Med"},{"key":"534_CR14","first-page":"1625","volume":"28","author":"JC Sisson","year":"1987","unstructured":"Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, Glownaik JV, Sherman P, Beierwaltes WH (1987) Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28:1625\u20131636","journal-title":"J Nucl Med"},{"key":"534_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00006231-199207000-00006","volume":"13","author":"KK Solanki","year":"1992","unstructured":"Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE (1992) A pharmacological guide to medicines which interfere with the biodistribution of radiolabeled meta-iodobenzylguanidine (MIBG). Nucl Med Commun 13:513\u2013521","journal-title":"Nucl Med Commun"},{"issue":"2 Pt 1","key":"534_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1071-3581(95)80023-9","volume":"2","author":"M Estorch","year":"1995","unstructured":"Estorch M, Carri\u00f3 I, Bern\u00e1 L, L\u00f3pez-Pousa J, Torres G (1995) Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol. 2(2 Pt 1):126\u2013132","journal-title":"J Nucl Cardiol."},{"issue":"15","key":"534_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12883-015-0338-9","volume":"15","author":"G Lamotte","year":"2015","unstructured":"Lamotte G, Morello R, Lebasnier A, Agostini D, Defer GL (2015) Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses. BMC Neurol 15(15):83","journal-title":"BMC Neurol"},{"issue":"6","key":"534_CR18","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00259-011-1754-8","volume":"38","author":"A Mux\u00ed","year":"2011","unstructured":"Mux\u00ed A, Paredes P, Navales I, Valldeoriola F, Gaig C, Lome\u00f1a F, de la Cerda A, Sol\u00e0 O, Domenech B, Tolosa E, Pons F (2011) Diagnostic cutoff points for 123I-MIBG myocardial scintigraphy in a Caucasian population with Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging 38(6):1139\u20131146","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"534_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/S0317167100031814","volume":"18","author":"A.H. Rajput","year":"1991","unstructured":"Rajput AH, Rozdilsky B (1991) Accuracy of clinical diagnosis in parkinsonism\u2014a prospective study. Can J Neurol Sci 18(3):275\u2013278","journal-title":"Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"},{"issue":"8","key":"534_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","volume":"57","author":"AJ Hughes","year":"2001","unstructured":"Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease. Neurology 57(8):1497\u20131499","journal-title":"Neurology"},{"issue":"3","key":"534_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/ane.12104","volume":"128","author":"S. Asayama","year":"2013","unstructured":"Asayama S, Wate R, Kaneko S, Asayama T, Oki M, Tsuge A, Nagashima M, Morita J, Nakamura S, Nakamura M, Nishii M, Fujita K, Saito A, Nakano S, Ito H, Kusaka H (2013) Levodopa challenge test and (123)I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson\u2019s disease. Acta Neurol Scand 128(3):160\u2013165","journal-title":"Acta Neurologica Scandinavica"},{"key":"534_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00702-002-0785-5","volume":"110","author":"F Yekhlef","year":"2003","unstructured":"Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F (2003) Routine MRI for the differential diagnosis of Parkinson\u2019s disease, MSA, PSP, and CBD. J Neural Transm 110:151\u2013169","journal-title":"J Neural Transm"},{"key":"534_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jns.2016.06.061","volume":"368","author":"Wataru Sako","year":"2016","unstructured":"Sako W, Abe T, Murakami N, Miyazaki Y, Izumi Y, Harada M, Kaji R (2016) Imaging-based differential diagnosis between multiple system atrophy and Parkinson\u2019s disease. J Neurol Sci 368:104\u2013108","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"534_CR24","doi-asserted-by":"publisher","first-page":"e61066","DOI":"10.1371\/journal.pone.0061066","volume":"8","author":"A Umemura","year":"2013","unstructured":"Umemura A, Oeda T, Hayashi R, Tomita S, Kohsaka M, Yamamoto K, Sawada H (2013) Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson\u2019s disease. PLoS One 8(4):e61066","journal-title":"PLoS One"},{"key":"534_CR25","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1093\/brain\/awr177","volume":"134","author":"JL Cummings","year":"2011","unstructured":"Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P (2011) The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134:3146\u20133166","journal-title":"Brain"},{"key":"534_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1159\/000115640","volume":"59","author":"AM Vlaar","year":"2008","unstructured":"Vlaar AM, de Nijs T, Kessels AG, Vreeling FW, Winogrodzka A, Mess WH, Tromp SC, van Kroonenburgh MJ, Weber WE (2008) Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with Parkinsonian syndromes. Eur Neurol 59:258\u2013266","journal-title":"Eur Neurol"},{"key":"534_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/RLU.0b013e3181d18cb3","volume":"35","author":"P Pifarr\u00e9","year":"2010","unstructured":"Pifarr\u00e9 P, Cuberas G, Hern\u00e1ndez J, Lorenzo C, Miquel F, Castell-Conesa J (2010) Cortical and subcortical patterns of I-123 iodobenzamide SPECT in striatal D(2) receptor parkinsonisms. Clin Nucl Med 35:228\u2013233","journal-title":"Clin Nucl Med"},{"issue":"11","key":"534_CR28","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s00259-010-1520-3","volume":"37","author":"SJ Mo","year":"2010","unstructured":"Mo SJ, Linder J, Forsgren L, Larsson A, Johansson L, Riklund K (2010) Pre- and postsynaptic dopamine SPECT in the early phase of idiopathic parkinsonism: a population-based study. Eur J Nucl Med Mol Imaging 37(11):2154\u20132164","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"534_CR29","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1474-4422(10)70002-8","volume":"9","author":"CC Tang","year":"2010","unstructured":"Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelber D (2010) Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 9:149\u2013158","journal-title":"Lancet Neurol"},{"key":"534_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.parkreldis.2013.04.015","volume":"8","author":"A Chiaravalloti","year":"2013","unstructured":"Chiaravalloti A, Stefani A, Pierantozzi M, Stanzione P, Schillaci O (2013) Does 123I-MIBG scintigraphy really assist the diagnosis of Parkinson\u2019s disease? Parkinsonism Relat Disord 8:772\u2013773","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"534_CR31","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1212\/01.wnl.0000252726.13187.63","volume":"67","author":"E. B. Montgomery","year":"2006","unstructured":"Montgomery EB Jr (2006) Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 67(12):2266\u20132267","journal-title":"Neurology"},{"issue":"1","key":"534_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/ene.12022","volume":"20","author":"A Berardelli","year":"2013","unstructured":"Berardelli A, Wenning GK, Antonini A, Berg D, Bloem BR, Bonifati V, Brooks D, Burn DJ, Colosimo C, Fanciulli A, Ferreira J, Gasser T, Grandas F, Kanovsky P, Kostic V, Kulisevsky J, Oertel W, Poewe W, Reese JP, Relja M, Ruzicka E, Schrag A, Seppi K, Taba P, Vidailhet M (2013) EFNS\/MDS-ES\/ENS recommendations for the diagnosis of Parkinson\u2019s disease. Eur J Neurol 20(1):16\u201334","journal-title":"Eur J Neurol"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-0534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-018-0534-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-018-0534-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T08:23:11Z","timestamp":1720340591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-018-0534-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,5]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s10286-018-0534-y","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"type":"print","value":"0959-9851"},{"type":"electronic","value":"1619-1560"}],"subject":[],"published":{"date-parts":[[2018,6,5]]},"assertion":[{"value":"13 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest with respect to the research, authorship, and\/or publication of the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare that this study has been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}